Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

Background. Recent advances in the treatment of relapsed/refractory acute lymphoblastic leukemia (R/R ALL) are attributed to the implementation of immunotherapy methods which include blinatumomab, the bispecific engager of a patient’s endogenous T-cells (Blincyto™, Amgen®) (BC). Aim. To assess BC e...

Full description

Bibliographic Details
Main Authors: SN Bondarenko, EN Parovichnikova, AA Maschan, OYu Baranova, TV Shelekhova, VA Doronin, VYa Mel’nichenko, KD Kaplanov, OS Uspenskaya, AN Sokolov, NV Myakova, IS Moiseev, IV Markova, EI Darskaya, AG Smirnova, TA Bykova, BI Ayubova, IA Samorodova, EV Babenko, IM Barkhatov, TL Gindina, AD Kulagin, BV Afanas’ev
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2019-03-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
acute lymphoblastic leukemia
targeted therapy
blinatumomab
Online Access: http://bloodjournal.ru/wp-content/uploads/2019/03/4-1.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2019/03/4-1.pdf

Similar Items